Related Experiment Videos
The discovery and development of angiotensin II antagonists
D J Carini1, D D Christ, J V Duncia
1DuPont Merck Pharmaceutical Company, Wilmington, Delaware 19880-0500, USA.
Pharmaceutical Biotechnology
|October 7, 1998
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Glucuronidation in the chimpanzee (Pan troglodytes): studies with acetaminophen, oestradiol and morphine.
Xenobiotica; the fate of foreign compounds in biological systems·2006
Identification of selective inhibitors of cyclin dependent kinase 4.
Bioorganic & medicinal chemistry letters·2001
Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor efavirenz.
Bioorganic & medicinal chemistry letters·2001
Mass spectrometric and NMR characterization of metabolites of roxifiban, a potent and selective antagonist of the platelet glycoprotein IIb/IIIa receptor.
Xenobiotica; the fate of foreign compounds in biological systems·2001
Fundamentals of freeze-drying.
Pharmaceutical biotechnology·2002
Fundamentals of thermal sterilization processes.
Pharmaceutical biotechnology·2002
Effects of conformation on the chemical stability of pharmaceutically relevant polypeptides.
Pharmaceutical biotechnology·2002
Vitamin B12 transporters.
Pharmaceutical biotechnology·2000
Multidrug-resistance transporters.
Pharmaceutical biotechnology·2000
Nucleoside transporters of mammalian cells.
Pharmaceutical biotechnology·2000
Second-generation H1 antihistamines for the treatment of chronic urticaria: a network meta-analysis.
Frontiers in medicine·2026
Carbon dots derived from natural medicines: Therapeutic advances and challenges.
Journal of pharmaceutical analysis·2026